Growth-suppressive activities of serine protease inhibitors, ONO-3403 and ONO-5046, toward normal and transformed murine fibroblasts

Anticancer Research

Volumn 16, Issue 4 A, 1996, Pages 1823-1826

  Hiwasa, Takaki ^a   Ohkoshi, Motohiro ^b  

^a CHIBA CANCER CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anticancer drug; Mouse fibroblast; Mtt; Serine protease inhibitor

Indexed keywords

ELASTASE; ETHYL N ALLYL N [2 METHYL 3 [4 (4 AMIDINOPHENOXYCARBONYL)PHENYL]PROPENOYL]AMINOACETATE METHANESULFONATE; ONO 3403; SERINE PROTEINASE INHIBITOR; SIVELESTAT; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG SENSITIVITY; FIBROBLAST; KIRSTEN SARCOMA ONCOVIRUS; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL;

3T3 CELLS; ALLYLGLYCINE; ANIMALS; BENZAMIDINES; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, RAS; GLYCINE; MICE; MICE, INBRED BALB C; MOLECULAR STRUCTURE; SERINE PROTEINASE INHIBITORS; SIMIAN VIRUS 40; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

EID: 0029760496     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Troll W, Klassen A and Janoff A: Tumorigenesis in mouse skin: Inhibition by synthetic inhibitors of proteases. Science 169: 1211-1213, 1970.
2. Rossman TG and Troll W: Protease inhibitors in carcinogenesis. In: Slaga TG (ed), Carcinogenesis: Modifiers of Chemical Carcinogenesis. New York, Raven Press, 1980, pp 127-143.
3. Weed H, McGandy RB and Kennedy AR: Protection against dimethylhydrazine induced adenomatous tumors of the mouse colon by the dietary addition of an extract of soybeans containing the Bowman-Birk protease inhibitor. Carcinogenesis 6: 1239-1241, 1985.
4. Witschi H and Kennedy AR: Modulation of lung tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor. Carcinogenesis 10: 2275-2277, 1989.
5. St. Clair W, Billing P, Carew J, Keller-McGandy C, Newberne P and Kennedy AR: Suppression of DMH-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor. Cancer Res 50: 580-586, 1990.
6. Kennedy AR: Anticarcinogenic activity of protease inhibitors. In: Troll W and Kennedy AR (eds), Protease inhibitors as cancer chemopreventive agents. New York, Plenum Press, 1993, pp 9-64.
7. Tamura Y, Hirano M, Okamura K, Minato Y and Fujii S: Synthetic inhibitor of trypsin, plasmin, kallikrein, thrombin. Cir C1 elastase. Biochim Biophys Acta 484: 417-422, 1977.
8. Ohkoshi M: Inhibition of growth of 3-methylcholanthrene-induced mouse skin tumor by protease inhibitor [N,N-dimetriylcarbamoylmethyl, 4-(4-guanidinobenzoyloxy)-phenyla-ceta-te]methanesulfate. Jpn J Cancer Res 72: 959-964, 1981.
9. Ohkoshi M and Fujii S: Effect of oral administration of protease inhibitor [N,N-dimethylcarnamoylmethyl, 4-(4-guanidinobenzoyloxy)-phenylacetate]methanesulfate on the growth of 3-methylcholanthrene-induced carcinoma in mice. Jpn J Cancer Res 73: 108-110, 1982.
10. Ohkoshi M and Fujii S: Effect of the synthetic protease inhibitor [N,N-dimethylcarbamoylmethyl, 4-(4-guanidinobenzoyloxy)-phenylacetate]methanesulfate on carcinogenesis by 3-methyl-cholanthrene in mouse skin. J Natl Cancer Inst 71: 1053-1057, 1983.
11. Ohkoshi M, Akagawa T and Nakajima M: Effects of serine protease inhibitor FOY-305 and heparin on the growth of squamous cell carcinoma. Anticancer Res 13: 963-966, 1993.
12. Senokuchi K, Nakai H, Nakayama Y, Odagaki Y, Sakaki K, Kato M, Maruyama T, Miyazaki T, Ito H, Kamiyasu K, Kim S, Kawamura M and Hamanaka N: New orally active serine protease inhibitors. J Med Chem 38: 2521-2523, 1995.
13. Kawabata K, Suzuki M, Sugitani M, Imaki K, Toda M and Miyamoto T: ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun 17: 814-820, 1991.
14. Hiwasa T, Fujimura S and Sakiyama S: Tumor promoters increase the synthesis of a 32,000-dalton protein in BALB/c 3T3 cells. Proc Natl Acad Sci USA 79: 1800-1804, 1982.
15. Hiwasa T and Sakiyama S: Altered properties of cAMP-dependent protein kinase in H-ras-transformed NIH3T3 cells. Biochem Biophys Res Commun 139: 787-793, 1986.
16. Hiwasa T, Soeda C, Takanohashi S, Kobayashi H, Suzuki A, Ueyama T and Ike Y: Screening of peptides which suppress the proliferation of transformed cells. Int J Oncol 8: 125-129, 1996.
17. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
18. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA and Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348-2357, 1986.
19. Mosmann TR and Fong TAT: Specific assays for cytokine production by T cells. J Immunol Methods 116: 151-158, 1989.
20. Kenndy AR: In vitro studies of anticarcinogenic protease inhibitors. In: Troll W and Kennedy AR (eds). Protease inhibitors as cancer chemopreventive agents. New York, Plenum Press, 1993, pp 65-91.
21. Lowy DR and Willumsen BM: Function and regulation of ras. Annu Rev Biochem 62: 851-891, 1993.